MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

RXi Pharmaceuticals Corp Company Profile (NASDAQ:RXII)

Consensus Ratings for RXi Pharmaceuticals Corp (NASDAQ:RXII) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (1,119.51% upside)

Analysts' Ratings History for RXi Pharmaceuticals Corp (NASDAQ:RXII)
Show:
DateFirmActionRatingPrice TargetActions
3/31/2015HC WainwrightLower Price TargetBuy$9.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014HC WainwrightSet Price TargetBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014LaidlawInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2014HC WainwrightInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha